Literature DB >> 23054752

Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.

Diego Marquez-Medina1, Joel Salla-Fortuny, Antonieta Salud-Salvia.   

Abstract

The gamma-delta (γδ) T-cells are a subset of T-lymphocytes characterized by the presence of a surface antigen recognition complex type 2. Those γδ T-cells represent 2-5 % of peripheral T-cells only, but they are common in organs and mucosae, acting as a first defense system in the entries to the organism. The γδ T-cells take part on immune response by direct cytolysis, development of memory phenotypes, and modulation of immune cells, and they have been implied in autoimmune disorders, immune deficiencies, infections, and tumor diseases. We reported the role of γδ T-cells in oncology, focusing in their potential applications for cancer treatment. Experimental designs and clinical trials in the treatment of solid malignancies are extensively reviewed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054752     DOI: 10.1007/s12094-012-0935-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  78 in total

1.  Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Authors:  Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C Hayday
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 3.  Newly identified gamma delta and beta delta T-cell receptors.

Authors:  F Hochstenbach; M B Brenner
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

4.  The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors.

Authors:  O Acuto; R E Hussey; K A Fitzgerald; J P Protentis; S C Meuer; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

5.  Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.

Authors:  Hirohito Kobayashi; Yoshimasa Tanaka; Junji Yagi; Yukinari Osaka; Hayakazu Nakazawa; Takehiko Uchiyama; Nagahiro Minato; Hiroshi Toma
Journal:  Cancer Immunol Immunother       Date:  2006-07-19       Impact factor: 6.968

6.  Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model.

Authors:  Takeshi Yuasa; Kiyoshi Sato; Eishi Ashihara; Miki Takeuchi; Shinya Maita; Norihiko Tsuchiya; Tomonori Habuchi; Taira Maekawa; Shinya Kimura
Journal:  Cancer Immunol Immunother       Date:  2008-08-06       Impact factor: 6.968

7.  Zoledronic acid-induced IPP/ApppI production in vivo.

Authors:  Hannu Mönkkönen; Penelope D Ottewell; Johanna Kuokkanen; Jukka Mönkkönen; Seppo Auriola; Ingunn Holen
Journal:  Life Sci       Date:  2007-08-17       Impact factor: 5.037

8.  The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.

Authors:  Yan Kong; Wei Cao; Xueyan Xi; Chi Ma; Lianxian Cui; Wei He
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

9.  Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta(+) t-cell receptors.

Authors:  M Ferrarini; S Heltai; S M Pupa; S Mernard; R Zocchi
Journal:  J Natl Cancer Inst       Date:  1996-04-03       Impact factor: 13.506

10.  Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication.

Authors:  Chiara Agrati; Tonino Alonzi; Rafaella De Santis; Concetta Castilletti; Isabella Abbate; Maria Rosaria Capobianchi; Gianpiero D'Offizi; Francesca Siepi; Gian Maria Fimia; Marco Tripodi; Fabrizio Poccia
Journal:  Int Immunol       Date:  2005-12-16       Impact factor: 4.823

View more
  10 in total

Review 1.  Spleen: Reparative Regeneration and Influence on Liver.

Authors:  Andrey Elchaninov; Polina Vishnyakova; Gennady Sukhikh; Timur Fatkhudinov
Journal:  Life (Basel)       Date:  2022-04-22

2.  Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery.

Authors:  Olesja Fornara; Jenny Odeberg; Nina Wolmer Solberg; Charlotte Tammik; Petra Skarman; Inti Peredo; Giuseppe Stragliotto; Afsar Rahbar; Cecilia Söderberg-Nauclér
Journal:  Oncoimmunology       Date:  2015-06-05       Impact factor: 8.110

3.  High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy.

Authors:  Avinash Eranki; Priya Srinivasan; Mario Ries; AeRang Kim; Christopher A Lazarski; Christopher T Rossi; Tatiana D Khokhlova; Emmanuel Wilson; Susan M Knoblach; Karun V Sharma; Bradford J Wood; Chrit Moonen; Anthony D Sandler; Peter C W Kim
Journal:  Clin Cancer Res       Date:  2019-10-15       Impact factor: 13.801

4.  Alpha-bisabolol, not a matter for cancer therapy. Commentary: "Research on the immunosuppressive activity of ingredients contained in sunscreens".

Authors:  Salvatore Chirumbolo
Journal:  Front Pharmacol       Date:  2015-05-11       Impact factor: 5.810

5.  Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro.

Authors:  Xiaohuan Liu; Ting Feng; Tianxiang Gong; Chongyang Shen; Tingting Zhu; Qihong Wu; Qiang Li; Hong Li
Journal:  Biomed Res Int       Date:  2015-04-14       Impact factor: 3.411

6.  Synthesis of medronic acid monoesters and their purification by high-performance countercurrent chromatography or by hydroxyapatite.

Authors:  Elina Puljula; Jouko Vepsäläinen; Petri A Turhanen
Journal:  Beilstein J Org Chem       Date:  2016-10-07       Impact factor: 2.883

7.  Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers.

Authors:  Ghita Chabab; Florence Boissière-Michot; Caroline Mollevi; Jeanne Ramos; Evelyne Lopez-Crapez; Pierre-Emmanuel Colombo; William Jacot; Nathalie Bonnefoy; Virginie Lafont
Journal:  Cells       Date:  2020-06-24       Impact factor: 6.600

Review 8.  Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma.

Authors:  Fabio Morandi; Francesco Frassoni; Mirco Ponzoni; Chiara Brignole
Journal:  J Immunol Res       Date:  2018-10-30       Impact factor: 4.818

Review 9.  Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy.

Authors:  Ghita Chabab; Clément Barjon; Nathalie Bonnefoy; Virginie Lafont
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

Review 10.  Immune cells in liver regeneration.

Authors:  Na Li; Jinlian Hua
Journal:  Oncotarget       Date:  2017-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.